Long-term PPI use may cause serious hypomagnesemiaU.S. FDA communicating safety concerns regarding potential development of hypomagnesemia when PPIs taken for prolonged periods. Gilenya: new MS drug approved by Health CanadaHealth Canada approves first disease-modifying oral treatment for multiple sclerosis in Canada. Obesity | Patients really do heed your weight-loss advice Cardiology | Drink to your health Researchers sharpen artery screening tool Study results may enable better use of intimal medial thickness measurements Celebrating a century of care at Women’s College Hospital On what is also the centennial of International Women’s Day, we look back on 100 years of a remarkable Canadian institution Rethink emphasis on weight loss in obese patients ‘Health at Every Size’ initiative emphasizes healthy behaviours over dropping pounds Coronary CT angiography aids diagnosis of arterial disease With the aid of coronary CT angiography (cCTA), researchers may have found a better way to identify heart disease in African-Americans and in certain obese individuals. Should patients with ‘mild’ strokes get tPA? Few receive the clot buster, despite substantial risk of disability Drug fails to aid subarachnoid hemorrhage recovery Clazosentan does not reduce vasospasm after surgery, Canadian-led researchers find First Previous 408 409 410 411 412 Next Last
